Matteo Droghetti retweeted
Read European Urology Oncology's latest article published online, by Lorenzo Bianchi et al.
Thank you for your contribution!
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology—Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
Explore the full study at: euoncology.europeanurology.c…
@Lorenzo26232839
@drMDrog
@cal_Catanzaro
@MRoupret
@CaPsurvivorshop
@Ric_Campi
@jteoh_hk
@UroDocAsh
@Uroweb
@F_Montorsi
@Albert0Briganti
@ClaudiaKesch
@roodvdb
@riccardosciav6
@dr_rajwa
#UroOncology #ProstateCancer #MensHealth #eau #YAU #urologist
Great to see published our efforts made during the period at @NKI_nl !
Kudos to @oktyzmn and all the team!!!
Our paper from @NKI_nl showed PSMA PET/CT has a lymph node tumor burden-dependent #diagnosticability and consequently a strong independent #prognosticvalue for predicting #BCR after RP.
mdpi-res.com/d_attachment/jc…
@drMDrog @RobertoContieri
Matteo Droghetti retweeted
How important is knowledge of anatomy for the surgeons of the next gen? learn with the brightest young urologists and anatomists at the university of bologna
@Eugenio74446325
@aleantonellibs1
@minerviniandre
@agalfano
@pietropiazza
@paolo_delloglio
@GGandaglia
@RicBertolo
@andreamari08
@AngeloMottaran
@drMDrog
Great to see on @JUrology out results on oncological outcomes of sentinel node location in prostate cancer!
@NKI_nl @oktyzmn @hvdpoel @riccardoschiav6 @Eugenio74446325
Check out the PDF at jurology.com/eprint/MK8SRHST…
Matteo Droghetti retweeted
Catching up some reading & good to see initial conclusions confirmed in longer term results, that adj RT after RP doesn’t improve FFDM or OS & ⬆️ toxicity compared to salvage.
There is slight curve sep at 10 years for FFDM with p = 0.09 but seems unlikely to become clinically relevant.
secure.jbs.elsevierhealth.co…
❓Could PSMA expression on PCa biopsy cores help select patients for PSMA pet?
▶️ Check out our recently published study
@FrontOncology @Eugenio74446325 @riccardoschiav6 @stefanofanti4 @Lorenzo26232839 @pietropiazza @AngeloMottaran
frontiersin.org/journals/onc…
Matteo Droghetti retweeted
1st Edition of the Italian #ESUBootCamp - It's a wrap!
A big thank you to all the trainees, the faculty, @UrowebESU @SIU_Italia @HUNIMED for making this a fantastic opportunity for young urology residents to gain hands-on training. #UrologyTraining
@NBuffi @tiago_urology
Very happy to be part of the first 🇮🇹 #ESU boot camp as a trainer today. Thanks to @HUNIMED , @SIU_Italia and @UrowebESU
Matteo Droghetti retweeted
🔍 New study sheds light on prostate cancer treatment outcomes!
🤔While biochemical recurrence is more common post-radical prostatectomy, the mortality risk is higher post-radiotherapy.
🩺 Rethinking our approach to BCR is crucial to optimize patient care and reduce overtreatment. 🚫
#prostatecancer #ProstateCancerAwarenessMonth
@JAMANetworkOpen @OncoAlert @APCCC_Lugano @PCFnews @Tilki_De @piet_ost @AlbertoBossial @GGiannarini @Uromigos @urotoday @Uroweb @zklaassen_md @amerseburger
doi:10.1001/jamanetworkopen.2023.32900
Our new paper evaluating association of post-RP radiotherpy with other-cause mortality is out!
This understudied survival which may be indicator of a proper pts selection for a particular tx needs to be established well.
@drMDrog
link.springer.com/article/10…
Matteo Droghetti retweeted
“It’s unethical to prescribe ADT alone for metastatic prostate cancer”. Strong words from Urologist Prof Fred Saad on latest GU Cast. Also, “urologists shouldn’t dabble in metastatic prostate cancer”. Don’t be a dabbler! – at Melbourne, Victoria
Urologists take note! ARPIs getting reimbursed for mHSPC. GU Cast is back with with Fred Saad, @ciaraconduit @RenuEapen @declangmurphy
youtu.be/xNl2JIQN82k
❓❓Challenging case
74yo iPSA 10ng/ml cT1 DRE cT2 mpMRI 8/16 cores positive for ISUP 5 #prostatecancer .
Staged with #wbMRI showing 10 suspicious bone Mets. Further scanned with #PSMA PET, negative for M+ or N+ lesion, just local prostate uptake.
What to do ?
100%Radical treatment
0%Adt+abi/enza+-docetaxel
0%Other
1 votes • Final results Matteo Droghetti retweeted
In well selected patients - solitary tumors < 7 cm, no or unilateral hydronephrosis, minimal CIS - results with TMT are comparable to Radical Cystectomy
#patientchoice #bladdercancer #BladderCancerMonth23
thelancet.com/journals/lanon…
@TheLancetOncol @BladderCancerUS
Matteo Droghetti retweeted
#ENZAMET
✅ Trial design and contemporaneous cohorts explained
✅ OS triplet findings for de novo mHSPC align with #PEACE1 & #ARASENS
✅ Proposed treatment plans by prognostic group
Lancet Onc pub & appendix: downloads here
✅bit.ly/ENZAMETLancet23
✅ bit.ly/ENZAMETLancet23Sup
Matteo Droghetti retweeted
🆕 Offer patients with cN1 disease a local treatment (either radical prostatectomy or IMRT/VMAT plus IGRT) plus long-term androgen-deprivation therapy.
#ProstateCancer #EAUguidelines
uroweb.org/guidelines/prosta…
Matteo Droghetti retweeted
New article (Vol. 183)
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients
Marcin Miszczyk et al.
doi.org/10.1016/j.radonc.202…